FGF21, a class of hepatokines that regulate lipid and glucose metabolism, has garnered much attention due to its translational potential for the management of obesity-related metabolic comorbidities [306,307,308]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.